Lookup NU author(s): Dr Jamie Willows,
Dr Katrina Wood,
Dr Helen Bourne,
Professor John Sayer
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
© BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.Acquired C1-inhibitor (C1-INH) deficiency is a rare and potentially life-threatening disorder, which presents with recurrent attacks of non-pitting oedema to the face, airway, limbs or gastrointestinal tract. It is often associated with underlying B-cell lymphoproliferative disorders. We describe a case of a 73-year-old man with acquired C1-INH deficiency who presented with nephrotic syndrome due to glomerular IgM deposition, secondary to an underlying secretory lymphoplasmacytic lymphoma. Both the acquired C1-INH deficiency and the nephrotic syndrome resolved when the underlying B-cell lymphoma was treated with rituximab and bendamustine, suggesting the underlying lymphoproliferative malignancy was driving both disorders.
Author(s): Willows J, Wood K, Bourne H, Sayer JA
Publication type: Article
Publication status: Published
Journal: BMJ case reports
Online publication date: 11/07/2019
Acceptance date: 26/06/2019
ISSN (electronic): 1757-790X
Publisher: NLM (Medline)
PubMed id: 31300605
Altmetrics provided by Altmetric